Lennal slips over 2% after Q3 earnings miss, expectation of further supply chain challenges; KAR Auction pulls FY21 guidance, falls over 3% Check out this evening's top movers from around Wall Street, compiled by The Fly.
HIGHER
- Aprea Therapeutics (APRE) up 14.6% after announcing data from phase 1/2 trial of APR-246 in solid tumors
- Viridian Therapeutics (VRDN) up 7.5% after equity offering
- Genmab (GMAB) up 5.0% after getting FDA accelerated approval for TIVDAK with Seagen (SGEN)
- SmileDirectClub (SDC) up 3.5% after announcing plans to launch in France
- Herc Holdings (HRI) up 1.5% after raising EBITDA guidance
- Herbalife (HLF) up 0.6% after insider buy
DOWN AFTER EARNINGS
ALSO LOWER
- Verrica Pharma (VRCA) down 24.1% after disclosing CRL from FDA identifying deficiencies for VP-102
- RBC Bearings (ROLL) down 6.5% after equity offering
- Conformis (CFMS) down 5.9% after cutting Q3 product revenue guidance
- KAR Auction Services (KAR) down 3.1% after withdrawing FY21 guidance due to chip shortage
- Progressive (PGR) down 1.0% after filing mixed securities shelf
Symbols:
APRE VRDN GMAB SGEN SDC HRI HLF LEN VRCA ROLL CFMS KAR PGR Keywords: fly intel, wall street, afterhours, movers, top stories, stocks, Lennar